MAP Kinase Signaling
Phospho-ATF-2 (Thr69/71) Blocking Peptide
|
イイネ!(0)
|
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #1040S | 100 μg | 16,000 | |
|
ATF-2抗体製品一覧
| 使用目的 | |
| Phospho-ATF-2 (Thr69/71) Antibody (#9225)の反応をブロックし、抗体の反応特異性を確認するために使用 |
Western Blotting

Western blot analysis of whole cell lysates from NIH/3T3 cells treated and untreated with UV light, probed with Phospho-ATF-2 (Thr69/71) Antibody #9225 (left) and with the same antibody co-incubated with specific blocking peptide (right).
IHC-P (paraffin)

Immunohistochemical staining of paraffin-embedded human breast carcinoma, using Phospho-ATF-2 (Thr69/71) Antibody #9225 preincubated with irrelevant control peptide (left) and Phospho-ATF-2 (Thr69/71) Blocking Peptide (right).
The transcription factor ATF-2 (also called CRE-BP1) binds to both AP-1 and CRE DNA response elements and is a member of the ATF/CREB family of leucine zipper proteins (1). ATF-2 interacts with a variety of viral oncoproteins and cellular tumor suppressors and is a target of the SAPK/JNK and p38 MAP kinase signaling pathways (2-4). Various forms of cellular stress, including genotoxic agents, inflammatory cytokines, and UV irradiation, stimulate the transcriptional activity of ATF-2. Cellular stress activates ATF-2 by phosphorylation of Thr69 and Thr71 (2-4). Both SAPK and p38 MAPK have been shown to phosphorylate ATF-2 at these sites in vitro and in cells transfected with ATF-2. Mutations of these sites result in the loss of stress-induced transcription by ATF-2 (2-4). In addition, mutations at these sites reduce the ability of E1A and Rb to stimulate gene expression via ATF-2 (2).
-
Abdel-Hafiz, H.A. et al. (1992) Mol. Endocrinol. 6, 2079-2089.
-
Gupta, S. et al. (1995) Science 267, 389-393.
-
van Dam, H. et al. (1995) EMBO J. 14, 1798-1811.
-
Livingstone, C. et al. (1995) EMBO J. 14, 1785-1797.